John Kilhefner

John Kilhefner

Senior Managing Editor, Lango Franchise

John Kilhefner is Senior Managing Editor of the Luke Lango franchise, which includes Hypergrowth Investing, Innovation Investor, Crypto Investor Network, and more.
Kilhefner has contributed to media such as Benzinga, The Hill, Tip Ranks, Unwinnable, The Arcade Review, Five Out of Ten magazine, and ZAM. He has appeared in U.S. News and World Report, Kotaku, USA Today, and Game Developer.
He now runs his own creative agency focused on tech and cybersecurity, called Skellator, LLC.
Learn more here

Recent Articles

GoPro Inc (GPRO): GoPro Stock Pops 12% on … Pokemon Go?

By John Kilhefner, Senior Managing Editor, Lango Franchise

GoPro is surging by double digits on Monday on simple rumors and tangential news. GPRO stock might look like a better speculative bet, but it's still a speculative bet.

Box Office Recap: ‘The Secret Life of Pets’ Dominates

By John Kilhefner, Senior Managing Editor, Lango Franchise

The summer box office is going to have a hard time keeping up with last summer, but thanks to "The Secret Life of Pets" and a few holdovers, the numbers came in stronger than expected.

TWTR Stock: Twitter Inc Live Sports Debuts With Wimbledon

By John Kilhefner, Senior Managing Editor, Lango Franchise

Twitter (TWTR) just gave the world its first glimpse of live sports streaming with Wimbledon and a little help from ESPN.

Apple Inc.: The Brexit Vote Could Put a Hurting on AAPL Stock

By John Kilhefner, Senior Managing Editor, Lango Franchise

Citgroup analysts lowered their estimates on Apple (AAPL) stock, citing the Brexit vote as a factor affecting earnings. Should you still buy?

Insys Therapeutics Inc: FDA Approval of Syndros Sends INSY Stock SOARING

By John Kilhefner, Senior Managing Editor, Lango Franchise

INSY is flying high after posting 9% gains on the strength of Insys Therapeutics' now-FDA-approved drug, Syndros.

Load More